$RXMD CEO called in to SmallCapVoice.com, Inc. to answer questions recently submitted by the Company's shareholders. On the call she discusses the third quarter 2019 financial highlights, the outlook for the Company in 2020, the renegotiated Family Physicians Rx (FPRX) acquisition, reducing price by 36%, saving shareholders $1.1 million, and much more.